VTE incidence by Khorana score
| 1, low risk (n=260) | ≥2, high risk (n=212) | |
| Overall VTE incidence rate during entire follow-up period, cases per 100 PY | 16.0 | 22.4 |
| PE | 10.5 | 14.2 |
| DVT, lower extremity | 7.0 | 9.8 |
| DVT, upper extremity | 1.4 | 4.3 |
| Other | 1.4 | 1.4 |
| Overall VTE incidence rate or anticoagulant within 3 days of venous ultrasound, cases per 100 PY | 16.7 | 25.4 |
| Overall VTE incidence rate (first event of PE, DVT, or other) by baseline use of oral anticoagulant), cases per 100 PY | ||
| Yes | 23.1 | 17.4 |
| No | 15.3 | 22.9 |
| Overall VTE cumulative incidence during 6-month follow-up period, cases per 100 patients | 10.8 | 15.1 |
| PE | 6.5 | 9.4 |
| DVT, lower extremity | 6.2 | 7.6 |
| DVT, upper extremity | 1.2 | 3.8 |
| Other | 1.2 | 1.4 |
DVT, deep vein thrombosis; ICI, immune checkpoint inhibitor; PE, pulmonary embolism; PY, patient-years; VTE, venous thromboembolism.